newsfilter
← Latest News
GlobeNewswire·

Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®

ATLANTA, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed to improve the